» Articles » PMID: 35796049

Forced Expiratory Flows and Diffusion Capacity in Infants Born from Mothers with Pre-eclampsia

Overview
Date 2022 Jul 7
PMID 35796049
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Animal models suggest pre-eclampsia (Pre-E) affects alveolar development, but data from humans are lacking.

Objective: Assess the impact of Pre-E on airway function, diffusion capacity, and respiratory morbidity in preterm and term infants born from mothers with Pre-E.

Methods: Infants born from mothers with and without Pre-E were recruited for this study; term and preterm infants were included in both cohorts. Respiratory morbidity in the first 12 months of life was assessed through monthly phone surveys. Raised volume rapid thoracoabdominal compression and measurement of diffusion capacity of the lung to carbon monoxide (DLCO) were performed at 6 months corrected age.

Measurements And Main Results: There were 146 infants in the Pre-E cohort and 143 in the control cohort. The Pre-E cohort was further divided into nonsevere (N = 41) and severe (N = 105) groups. There was no significant difference in DLCO and DLCO/alveolar volume among the three groups. Forced vital capacity was similar among the three groups, but the nonsevere Pre-E group had significantly higher forced expiratory flows than the other two groups. After adjusting for multiple covariates including prematurity, the severe Pre-E group had a lower risk for wheezing in the first year of life compared to the other two groups.

Conclusions: Pre-E is not associated with reduced DLCO, lower forced expiratory flows, or increased wheezing in the first year of life. These results differ from animal models and highlight the complex relationships between Pre-E and lung function and respiratory morbidity in human infants.

Citing Articles

Decreased vascular reactivity associated with increased IL-8 in 6-month-old infants of mothers with pre-eclampsia.

Kua K, Rhoads E, Slaven J, Edwards S, Haas D, Ren C Pediatr Res. 2024; 96(4):976-982.

PMID: 38509229 PMC: 11413232. DOI: 10.1038/s41390-024-03132-4.


Forced expiratory flows and diffusion capacity in infants born from mothers with pre-eclampsia.

Ren C, Slaven J, Haas D, Haneline L, Tiller C, Hogg G Pediatr Pulmonol. 2022; 57(10):2481-2490.

PMID: 35796049 PMC: 9489632. DOI: 10.1002/ppul.26064.

References
1.
Le Cras T, Markham N, Tuder R, Voelkel N, Abman S . Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol. 2002; 283(3):L555-62. DOI: 10.1152/ajplung.00408.2001. View

2.
Sengupta P . The Laboratory Rat: Relating Its Age With Human's. Int J Prev Med. 2013; 4(6):624-30. PMC: 3733029. View

3.
Pole J, Mustard C, To T, Beyene J, Allen A . Antenatal steroid therapy for fetal lung maturation: is there an association with childhood asthma?. J Asthma. 2009; 46(1):47-52. DOI: 10.1080/02770900802262795. View

4.
Castillo A, Llapur C, Martinez T, Kisling J, Williams-Nkomo T, Coates C . Measurement of single breath-hold carbon monoxide diffusing capacity in healthy infants and toddlers. Pediatr Pulmonol. 2006; 41(6):544-50. DOI: 10.1002/ppul.20403. View

5.
Martinez F, Morgan W, Wright A, Holberg C, Taussig L . Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988; 319(17):1112-7. DOI: 10.1056/NEJM198810273191702. View